Related Experiment Video

Updated: Jun 5, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Association between liver steatosis and angiogenesis in chronic hepatitis C

Michał Kukla1, Andrzej Gabriel, Daniel Sabat

  • 1Department of Physiology in Zabrze, Medical University of Silesia, Katowice, Poland. kuklamich@poczta.onet.pl

Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists
|January 13, 2011
PubMed

Insights

Extensive liver steatosis in chronic hepatitis C (CHC) patients correlates with increased new blood vessel formation in liver lobules and portal tracts. This finding highlights the link between steatosis, fibrosis, and angiogenesis in CHC progression.

Area of Science:

  • Hepatology
  • Oncology
  • Vascular Biology

Background:

  • The interplay between hepatic steatosis and angiogenesis in chronic hepatitis C (CHC) remains incompletely understood.
  • Steatosis, characterized by fat accumulation in liver cells, and angiogenesis, the formation of new blood vessels, are key pathological processes in liver disease.

Purpose of the Study:

  • To investigate the association between the presence and extent of liver steatosis and the density of newly formed blood vessels in CHC patients.
  • To determine if steatosis influences the microvasculature within liver lobules and portal tracts.

Main Methods:

  • Evaluation of 72 CHC patients infected with viral genotype 1b, with 35 exhibiting steatosis.
  • Quantification of new blood vessel formation using monoclonal antibody anti-CD34 staining.
  • Assessment of CD34 expression in portal tracts (CD34pt), lobules and fibrous septa (CD34lfs), and overall (CD34).

Main Results:

  • Patients with steatosis showed significantly more advanced fibrosis and higher inflammatory activity.
  • Significantly elevated CD34 expression (indicating angiogenesis) was observed in portal tracts, lobules, and fibrous septa of patients with steatosis.
  • Angiogenesis markers (CD34, CD34pt, CD34lfs) demonstrated a significant correlation with the grade of steatosis.

Conclusions:

  • Extensive liver steatosis in CHC patients is linked to increased angiogenesis in both lobular and portal areas.
  • Understanding the nexus of steatosis, fibrosis, and angiogenesis is crucial for developing novel therapeutic strategies and assessing CHC disease progression.
Abstract

More Related Videos

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells09:15

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells

Published on: July 18, 2019

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...